Mmc Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 11-07-2024
- Paid Up Capital ₹ 6.13 M
as on 11-07-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.15 Cr
as on 11-07-2024
- Satisfied Charges ₹ 2.35 Cr
as on 11-07-2024
- Revenue 7.72%
(FY 2023)
- Profit 23.25%
(FY 2023)
- Ebitda 191.00%
(FY 2023)
- Net Worth 16.73%
(FY 2023)
- Total Assets 24.55%
(FY 2023)
About Mmc Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.13 M.
The company currently has active open charges totaling ₹6.15 Cr. The company has closed loans amounting to ₹2.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Girijadevi Jayaraman, Sureshbabu Makam, Mariappan Ravichandran, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24100TN2016PLC104768
- Company No.
104768
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mmc Pharmaceuticals Limited offer?
Mmc Pharmaceuticals Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Immunity Booster.
Who are the key members and board of directors at Mmc Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Malliah Rajarathinam  | Managing Director | 18-Mar-2016 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girijadevi Jayaraman | Director | 21-Mar-2016 | Current |
| Sureshbabu Makam | Director | 24-Dec-2018 | Current |
| Mariappan Ravichandran | Director | 21-Mar-2016 | Current |
| Malliah Vidyavathi | Director | 21-Mar-2016 | Current |
| Shanthi | Director | 18-Mar-2016 | Current |
| Rajarathinam Subash | Director | 18-Mar-2016 | Current |
Financial Performance of Mmc Pharmaceuticals.
Mmc Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.72% increase. The company also saw a substantial improvement in profitability, with a 23.25% increase in profit. The company's net worth Soared by an impressive increase of 16.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mmc Pharmaceuticals?
In 2023, Mmc Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Roorkee Research & Analytical Labs Private LimitedActive 18 years 1 month
Sureshbabu Makam is a mutual person
- Mmc Healthcare (Himachal Pradesh) Private LimitedActive 19 years 11 months
Mariappan Ravichandran and Malliah Rajarathinam are mutual person
- Sri Devi Distributors Private LimitedActive 10 years 3 months
Rajarathinam Subash is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 May 2018 | ₹6.15 Cr | Open |
State Bank Of India Creation Date: 27 Mar 2017 | ₹2.35 Cr | Satisfied |
How Many Employees Work at Mmc Pharmaceuticals?
Mmc Pharmaceuticals has a workforce of 281 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mmc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mmc Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
